News | PET-CT | February 10, 2016

New Wisconsin Health and Wellness Center Chooses Toshiba’s PET/CT System

System improves the patient experience, diagnostic confidence and image quality

Toshiba Celesteion PET/CT, Fox Valley Hematology & Oncology

February 10, 2016 — Patients at Fox Valley Hematology & Oncology’s (FVHO) new cancer care center are receiving a better imaging experience and more accurate positron emission tomography/computed tomography (PET/CT) scans with Toshiba America Medical Systems Inc.’s Celesteion PET/CT system.

The new FVHO Health & Wellness Center, which opened in September 2015, will use the Celesteion PET/CT system to image and plan treatment for cancer patients, as well as open up a new service line in the future for orthopedic imaging.

“The Celesteion is a ‘one-stop-shop’ system that can perform PET and CT imaging all at once, which eliminates the need to schedule multiple appointments, making imaging easier and faster for staff and patients,” said Sheri Krueger, diagnostic center coordinator, FVHO Health & Wellness Center. “In our experience, the system produces phenomenal and clear images with little to no artifacts, especially with larger patients. Additionally, claustrophobic patients regularly comment on the system’s large bore, which gives them a feeling of openness and more room.”

Toshiba’s Celesteion PET/CT system delivers a more comfortable patient experience with what the company calls the industry’s largest bore (90 cm CT and 88 cm PET), an expansive field-of-view and time-of-flight imaging. The versatile system combines high-performance PET and CT for all radiation and oncology imaging needs, including tumor detection, treatment evaluation and CT simulation. Helping to ensure patient safety is not a choice, Celesteion comes standard with Toshiba’s advanced CT dose reduction technology, AIDR 3D.

For more information: www.medical.toshiba.com

Related Content

News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
ScImage and Invia Partnership Announced
News | PACS | September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging | September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
German Team Optimizing Therapy Planning for Cancers of the Liver
News | Interventional Radiology | August 29, 2017
Radioembolization is a therapy method used for liver tumors that are uncurable with surgery or chemotherapy. Thorough...
Sponsored Content | Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
Overlay Init